Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For MTZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Balanced
50%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -6.59 1.31 1.40
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 38.61 20.51 14.79
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -1.26 34.31 34.75
Cash -52.96 3.20 6.80
Capex 28.63 -0.33 -0.46
Free Cash Flow -81.92 1.06 5.84
Revenue -18.15 34.47 42.12
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -6.29 0.06 0.07
Operating Margin -98.72 < 0.005 0.01
ROA 6002.42 < 0.005 < 0.005
ROE 5434.00 -0.02 < 0.005
ROIC -99.99 < 0.005 0.68
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of MTZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of MTZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of MTZ is permitted for members.